Japan approves Amgen's osteoporosis drug

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...

January 10, 2019 | Thursday | News
Daiichi Sankyo receives regulatory approval for hypertension tablets

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...

January 10, 2019 | Thursday | News
NapaJen Pharma closes $12.4M Series C financing

NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery...

January 9, 2019 | Wednesday | News
Takeda completes acquisition of Shire

Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (&...

January 8, 2019 | Tuesday | News
Fujifilm to invest 10B Yen in Bio CDMO biz

FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in ...

January 8, 2019 | Tuesday | News
Solasia initiates Phase III programme for PledOx

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...

January 7, 2019 | Monday | News
Otsuka, Click Therapeutics to create therapy for mental illness

Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therap...

January 7, 2019 | Monday | News
Takeda announces multiple cell therapy collaborations

Takeda Pharmaceutical  has announced new research collaborations in immuno-oncology (I-O), an area of key strategic...

January 4, 2019 | Friday | News
Researchers discover laminin which can convert stem cells into retinal-like cells

Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various ce...

January 2, 2019 | Wednesday | News
MediPharm Labs declares its addition to HMMJ Index

MediPharm Labs Corp., a specialized, research-driven cannabis extraction business licensed under the Cannabis Act, is pl...

December 31, 2018 | Monday | News
Taisho Pharmaceutical Holdings to purchase BMS's UPSA

Bristol-Myers Squibb Company recently announced that Taisho Pharmaceutical Holdings has offered to purchase Bristol-Myer...

December 30, 2018 | Sunday | News
Prevelance of colistin-resistance high in Vietnam: Research

A team of researchers led by Osaka University examined the dissemination of colistin-resistant bacteria among residents ...

December 28, 2018 | Friday | News
Chugai obtains approval for Genomic Mutation Analysis Program

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfa...

December 27, 2018 | Thursday | News
Rakuten Aspyrian closes $284 Million Series C Financing for late-stage oncology pipeline

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...

December 26, 2018 | Wednesday | News
Mundipharma applies for marketing Remimazolam in Japan

Mundipharma has submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimazola...

December 21, 2018 | Friday | News
Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...

December 20, 2018 | Thursday | News
Ajinomoto and XL-protein unite to develop therapeutic compounds

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in&nb...

December 19, 2018 | Wednesday | News
Fuji Pharma Invests in Alvotech for $50M

Biopharmaceutical company Alvotech has announced that Japan-based Fuji Pharma has acquired a 4.2% stake in the business ...

December 19, 2018 | Wednesday | News